Evidence map›Paper›PMID 30785647›Full record

ArticleCongenital anomalies2020

Association between hereditary predisposition to common cancers and congenital multimalformations.

Fabrice Kwiatkowski, Isabelle Perthus, Nancy Uhrhammer, Christine Francannet, Marie Arbre, Yannick Bidet, Yves-Jean Bignon

Open access · hybridAbstract read
In one paragraph

Article in Congenital anomalies, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Pregnancy after breast cancer in BRCA1/2 mutation carriers.Hereditary cancer in clinical practice · 2022
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fabrice KwiatkowskiOncogenetics Department, Centre Jean Perri (Comprehensive Cancer Center), Clermont-Ferrand, France.ORCID https://orcid.org/0000-0002-4041-3999
Isabelle PerthusMedical Genetics Department, Study Center of Congenital Malformations in Auvergne (Centre d'Etude des Malformations Congénitales en Auvergne), Clermont-Ferrand, France.
Nancy UhrhammerOncogenetics Department, Centre Jean Perri (Comprehensive Cancer Center), Clermont-Ferrand, France.
Christine FrancannetMedical Genetics Department, Study Center of Congenital Malformations in Auvergne (Centre d'Etude des Malformations Congénitales en Auvergne), Clermont-Ferrand, France.
Marie ArbreOncogenetics Department, Centre Jean Perri (Comprehensive Cancer Center), Clermont-Ferrand, France.
Yannick BidetOncogenetics Department, Centre Jean Perri (Comprehensive Cancer Center), Clermont-Ferrand, France.
Yves-Jean BignonOncogenetics Department, Centre Jean Perri (Comprehensive Cancer Center), Clermont-Ferrand, France.
Centre Jean Perrin · FR

Funding

Conseil Régional AuvergneFEDER (European Funding of Regional Development)FEDER (European Funding of Regional Development) and Conseil Régional Auvergne convention n°36760 (2013)
6 · The paper itself

Abstract

In a previous article we reported that mutations favoring cancer at adulthood seemed to improve fertility and limit miscarriages. Because spontaneous abortion may result from anomalies in embryo, we questioned if an increased frequency of congenital malformation could be evidenced among cancer-prone families. Oncogenetics database (≈193 000 members) of the comprehensive cancer center Jean Perrin was crossed with regional registry of congenital malformations (≈10 000). Among children born between 1986 and 2011, 176 children with malformation matched in both databases. In breast/ovaries cancer-prone families, the risk for malformations was multiplied by 2.4 [1.2-4.5] in case of a BRCA1 mutation. Frequencies of malformation in BRCA2 and MMR mutated families were similar to families without a cancer syndrome. In comparison to malformations concerning a unique anatomical system, multimalformations were significantly more frequent in case of BRCA or MMR mutations: compared to families without cancer syndrome, the risk of multimalformations was multiplied by 4.1 [0.8-21.7] for cancer-prone families but with no known deleterious mutation, by 6.9 [1.2-38.6] in families with a known mutation but an unknown parental mutational status and by 10.4 [2.3-46.0] when one parent carried the familial mutation. No association with the type of anatomical system was found, nor with multiple births. These results suggest that BRCA and MMR genes play an important role in human embryogenesis and that if their function is lowered because of heterozygote mutations, congenital malformations are either more likely (BRCA1 mutations) and/or more susceptible to concern several anatomical systems.

Indexed as

Genetic Predisposition to DiseaseAbortion, SpontaneousAdultBRCA1 ProteinBRCA2 ProteinBreast NeoplasmsChildCongenital AbnormalitiesEmbryonic DevelopmentFemaleGenetic Association StudiesGerm-Line MutationHumansOvarian NeoplasmsPedigreeReceptors, ImmunologicBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanmacrophage MHC receptor 1, humanReceptors, ImmunologicBRCAcancer syndromecongenital malformationHBOConcogenetics

Identifiers

PMID30785647
PMCPMC6973007
OpenAlexW2915857812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.